FDA Approves Delafloxacin (Baxdela) for Skin Infections – Medscape
Medscape |
FDA Approves Delafloxacin (Baxdela) for Skin Infections
Medscape The US Food and Drug Administration (FDA) today approved an antibiotic called delafloxacin (Baxdela, Melinta Therapeutics) to treat serious or life-threatening infections, including one that’s particularly tough to beat. A fluoroquinolone, delafloxacin … Melinta Therapeutics’s IV, oral delafloxacin wins an FDA nod in skin infections FDA approves Baxdela to treat acute bacterial skin infections New Antibiotic Baxdela Gets FDA Approval |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.